이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Investigating Nutrition and Functional Outcome in Critically Ill Patients (INFO)

2022년 5월 25일 업데이트: Christian Stoppe, RWTH Aachen University
This is a single-center, multi-ICU prospective observational trial evaluating current nutritional practice and its influence of the physical function of critically ill patients.

연구 개요

상세 설명

The investigators propose a prospective observational, single-center, multi-intensive care unit trial to evaluate the influence of current nutritional practice on the physical outcome in critically ill patients. At least 100 consecutive patients requiring surgery, who are admitted to any surgical ICU at the University Hospital RWTH Aachen will be recruited. Nutritional practices, such as dosage, timing and route of administration of the nutrition, as well as complications regarding the nutrition will be recorded and analyzed longitudinally from ICU-admission until hospital discharge. Patient outcomes, such as ICU- and hospital length of stay, duration of mechanical ventilation, organ dysfunction, complications and infections will be evaluated. To assess physical function of the patient, muscle mass, muscle strength, the ability of the patient to self-mobilize and perform every day activities will be measured.

This observational trial aims to assess the current standard of nutritional practice in the ICU, to detect problems and complications and to gather first evidences about the influence of nutrition on the physical function of the patient. This study also aims to compare the outcome of the predefined subgroups of critically ill patients.

연구 유형

관찰

등록 (실제)

100

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • NRW
      • Aachen, NRW, 독일, 52074
        • RWTH Aachen University Hospital

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 이상 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

샘플링 방법

비확률 샘플

연구 인구

This is a clinical trial, which will include critically ill patients after informed consent. Patients who admitted to a surgical ICU following surgery or requiring surgery can be screened and included by our team. The general eligibility criteria are listed above. We will recruit patients, who can be classified as one of the following groups: a) neurosurgical Patients, b) elderly patients, c) obese patients, d) cardiac surgery patients and e) abdominal surgery patients

설명

Inclusion Criteria:

  • Informed consent
  • Adult patients (≥ 18 years)
  • Patients admitted to a surgical ICU requiring surgical Intervention
  • Patients requiring sedation and invasive ventilation for ≥ 48 hours
  • Patients with an expected ICU-length of stay ≥ 72 hours

Exclusion Criteria:

  • Pregnant or lactating patients
  • Patients already receiving an intense nutrition support (home parenteral or enteral nutrition) in addition to normal nutrition on hospital admission
  • Patients with disabling disease (neurological or physical) that prevents them from walking, sitting or standing before ICU admission
  • Patients unable to follow orders from the study personnel (language barriers, neurological, psychiatric disorders)
  • Death expected within 96 hours after admission due to severity of disease
  • Enrolment in an industry sponsored randomized trial within the last 30 days (co-enrolment in academic randomized trials will be considered on a case by case basis)

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 관찰 모델: 보병대
  • 시간 관점: 유망한

코호트 및 개입

그룹/코호트
개입 / 치료
Neurosurgical patients

Non-elective admission to the neurosurgical ICU with one of the following acute intracranial pathologies which also serve as predefined subgroups:

  1. Intracranial hemorrhage (subarachnoid, subdural hemorrhage or intracerebral hemorrhage)
  2. Acute and severe head trauma with an initial Glasgow Coma Scale ≤10
Battery of tests, which measure the patients functional outcomes regarding their muscle mass, their muscle strength, fat mass, physical function, neuropsychological function and quality of life.
Elderly patients
Age ≥ 70 years, predefined subgroups: ≥ 70 years and ≥80 years
Battery of tests, which measure the patients functional outcomes regarding their muscle mass, their muscle strength, fat mass, physical function, neuropsychological function and quality of life.
Obese patients
BMI ≥ 35 kg/m2, furthermore predefined subgroups of patients with BMI ≥ 40 kg/m2 and BMI ≥ 45 kg/m2
Battery of tests, which measure the patients functional outcomes regarding their muscle mass, their muscle strength, fat mass, physical function, neuropsychological function and quality of life.
Cardiac surgery patients

Admission to the cardiosurgical ICU after one of the following procedures using cardiopulmonary bypass, which also serve as predefined subgroups:

  1. Coronary revascularization (coronary artery bypass graft)
  2. Heart valve surgery
  3. Combined or complex heart surgery
Battery of tests, which measure the patients functional outcomes regarding their muscle mass, their muscle strength, fat mass, physical function, neuropsychological function and quality of life.
Abdominal surgical patients
Admission to the abdominal surgery ICU after abdominal surgery
Battery of tests, which measure the patients functional outcomes regarding their muscle mass, their muscle strength, fat mass, physical function, neuropsychological function and quality of life.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Nutritional status - basic demographics
기간: at Study inclusion
Chart review
at Study inclusion
Nutritional Status - nutritional screening
기간: intensive care unit (ICU) admission, up to 1 week
Nutritional Risk Screening 2002 (Score: 0-7; if ≥3 patient at nutritional risk)
intensive care unit (ICU) admission, up to 1 week
Nutritional Status - nutritional risk in the critically ill (NUTRIC)
기간: ICU admission, up to 1 week
NUTRIC score (Score 0-10; if interleucin-6 (IL6) available 0-5=low malnutrition risk; if IL6 not available 0-4= at low malnutrition risk
ICU admission, up to 1 week
Nutritional Status - Waist and mid-arm circumferences
기간: Study inclusion, up to 1 week
Waist and mid-arm circumferences
Study inclusion, up to 1 week
Differences of dosage of nutrition
기간: until discharge from intensive care unit, an average of 30 days
Cumulative delivery of macronutrients by infusion rates
until discharge from intensive care unit, an average of 30 days
Differences of dosage of nutrition
기간: until discharge from intensive care unit, an average of 30 days
Cumulative delivery of macronutrients by cumulative count of macronutrients
until discharge from intensive care unit, an average of 30 days
Differences of dosage of nutrition
기간: until discharge from intensive care unit, an average of 30 days
Cumulative delivery of macronutrients by nutrition used
until discharge from intensive care unit, an average of 30 days
Timing of nutrition
기간: until discharge from intensive care unit, an average of 30 days
Chart Review- start and stop times
until discharge from intensive care unit, an average of 30 days
Timing of nutrition - reason for discontinuation
기간: at discharge from intensive care unit, an average of 30 days
Chart review
at discharge from intensive care unit, an average of 30 days
Differences in route of administration of nutrition
기간: discharge from intensive care unit, an average of 30 days
Rates of oral, enteral and parenteral nutrition, feeding tubes and catheters used for nutrition
discharge from intensive care unit, an average of 30 days
Incidence of Gastrointestinal symptoms
기간: discharge from intensive care unit, an average of 30 days
Chart review (vomiting, nausea, high gastric residual volumes, diarrhea, obstipation, aspiration, ileus, bowel ischemia)
discharge from intensive care unit, an average of 30 days
Incidence Blood work irregularities
기간: discharge from intensive care unit, an average of 30 days
Chart review (electrolyte imbalance, blood sugar imbalance, dyslipidemia)
discharge from intensive care unit, an average of 30 days
Incidence of Refeeding syndrome
기간: discharge from intensive care unit, an average of 30 days
Chart review
discharge from intensive care unit, an average of 30 days
Incidence of complications related to the route of administration
기간: discharge from intensive care unit, an average of 30 days
Chart review (central venous catheter infection, misplaced and dislocated enteral feeding tubes)
discharge from intensive care unit, an average of 30 days
Nutrition adequacy
기간: discharge from intensive care unit, an average of 30 days
Rates of energy and protein received in comparison to nutritional targets Chart review
discharge from intensive care unit, an average of 30 days
Change in Muscle mass - Mid-arm circumference (MAC)
기간: Study inclusion, discharge from intensive care unit and hospital discharge, up to 3 months
MAC
Study inclusion, discharge from intensive care unit and hospital discharge, up to 3 months
Change in Muscle mass - Quadriceps thickness
기간: Study inclusion, discharge from intensive care unit and hospital discharge, up to 3 months
ultrasound
Study inclusion, discharge from intensive care unit and hospital discharge, up to 3 months
Change in Muscle mass - Quadriceps cross sectional area
기간: Study inclusion, discharge from intensive care unit and hospital discharge, up to 3 months
ultrasound
Study inclusion, discharge from intensive care unit and hospital discharge, up to 3 months
Change in Muscle strength - Handgrip strength
기간: discharge from intensive care unit and hospital discharge, up to 3 months
Dynamometry
discharge from intensive care unit and hospital discharge, up to 3 months
Change in Muscle strength - Quadriceps strength
기간: discharge from intensive care unit and hospital discharge, up to 3 months
Dynamometry
discharge from intensive care unit and hospital discharge, up to 3 months
Change in Physical function - Functional Status Score for the ICU
기간: discharge from intensive care unit and hospital discharge, up to 3 months
Functional Status Score for Intensive Care Unit (FSS-ICU) (Score 0-35; the higher the score, the better physical functioning)
discharge from intensive care unit and hospital discharge, up to 3 months
Change in Physical function - Short Physical Performance Battery
기간: discharge from intensive care unit and hospital discharge, up to 3 months
Short Physical Performance Battery (SPPB) (Score: 0-12; 0=worst performance and 12=best performance)
discharge from intensive care unit and hospital discharge, up to 3 months
Change in Physical function - 6-Minute Walk Test
기간: discharge from intensive care unit and hospital discharge, up to 3 months
6-minute walking distance
discharge from intensive care unit and hospital discharge, up to 3 months
Change in Physical function - Manual Muscle Testing (MMT)
기간: discharge from intensive care unit and hospital discharge, up to 3 months
MMT
discharge from intensive care unit and hospital discharge, up to 3 months
Change in Physical function - Katz Activities of Daily Living (ADL)
기간: Hospital discharge, day 30 after study inclusion, up to 3 months
ADL (Score: 0-100; the higher the more independent)
Hospital discharge, day 30 after study inclusion, up to 3 months
Change in Physical function - Lawton Instrumental Activities of Daily Living (IADL)
기간: Hospital discharge, day 30 after study inclusion, up to 3 months
IADL (score 0-8; the higher the more independent)
Hospital discharge, day 30 after study inclusion, up to 3 months
Change in Physical function - Clinical Frailty Score (CFS)
기간: Study inclusion, Hospital discharge, day 30 after study inclusion, up to 3 months
CFS (score 1-9; 1= Very fit and 9=terminally ill)
Study inclusion, Hospital discharge, day 30 after study inclusion, up to 3 months
Change in Fat mass
기간: Study inclusion, discharge from intensive care unit and hospital discharge, up to 3 months
Thigh and abdominal fat (ultrasound)
Study inclusion, discharge from intensive care unit and hospital discharge, up to 3 months
Change in Neuro-psychological function - Mini Mental State Examination (MMSE)
기간: discharge from intensive care unit, Hospital discharge, day 30 after study inclusion, up to 3 months
MMSE (Score 0-30; 30= no dementia and <9= severe dementia)
discharge from intensive care unit, Hospital discharge, day 30 after study inclusion, up to 3 months
Change in Neuro-psychological function - Becks Depression Inventory (BDI)
기간: discharge from intensive care unit, Hospital discharge, day 30 after study inclusion, up to 3 months
BDI (Score 0-63; 0= no depression and 63= severe depression)
discharge from intensive care unit, Hospital discharge, day 30 after study inclusion, up to 3 months
Quality of life - Short Form 36 (SF-36)
기간: day 30 after study inclusion
SF-36 (Score: 0-100; 100=no limitation in daily life and 0=completely limited)
day 30 after study inclusion
Quality of life - Living location
기간: day 30 after study inclusion
Rates of patients being discharged to nursing home, rehabilitation, home care etc. Discharge location used as surrogate for physical fitness after hospital discharge.
day 30 after study inclusion

2차 결과 측정

결과 측정
측정값 설명
기간
Mortality Rate
기간: up to 30 days after study inclusion
Mortality
up to 30 days after study inclusion
Length of stay - intensive care unit length of stay
기간: discharge from intensive care unit, an average of 30 days
ICU length of stay
discharge from intensive care unit, an average of 30 days
Length of stay - Hospital length of stay
기간: Hospital discharge, an average of 60 days
Hospital length of stay
Hospital discharge, an average of 60 days
Readmission - ICU readmission rate
기간: Hospital discharge, day 30 after study inclusion, up to 3 months
ICU readmission rate
Hospital discharge, day 30 after study inclusion, up to 3 months
Readmission - Hospital readmission rate
기간: up to 30 days after study inclusion, up to 3 months
Hospital readmission rate
up to 30 days after study inclusion, up to 3 months
Change in acute organ dysfunction - sepsis-related organ failure assessment (SOFA score)
기간: up to discharge from intensive care unit, an average of 30 days
daily records (score 0-24; 0=normal function and 24= massively impaired function)
up to discharge from intensive care unit, an average of 30 days
Acute organ dysfunction - hemodynamic parameters
기간: up to discharge from intensive care unit, an average of 30 days
blood pressure in mmHg
up to discharge from intensive care unit, an average of 30 days
Acute organ dysfunction - hemodynamic parameters
기간: up to discharge from intensive care unit, an average of 30 days
vasopressors, cumulative dosage in ml/d
up to discharge from intensive care unit, an average of 30 days
Acute organ dysfunction - hemodynamic parameters
기간: up to discharge from intensive care unit, an average of 30 days
heart rate bpm
up to discharge from intensive care unit, an average of 30 days
Acute organ dysfunction - incidence of ventilation
기간: up to discharge from intensive care unit, an average of 30 days
mode of ventilation
up to discharge from intensive care unit, an average of 30 days
Acute organ dysfunction - duration of ventilation
기간: up to discharge from intensive care unit, an average of 30 days
hours of ventilation
up to discharge from intensive care unit, an average of 30 days
Acute organ dysfunction - sedation
기간: up to discharge from intensive care unit, an average of 30 days
duration of sedation in hours
up to discharge from intensive care unit, an average of 30 days
Acute organ dysfunction - sedation
기간: up to discharge from intensive care unit, an average of 30 days
dosage of sedation, cumulative dosage in ml/d
up to discharge from intensive care unit, an average of 30 days
Acute organ dysfunction - Richmond Agitation Scale
기간: up to discharge from intensive care unit, an average of 30 days
Richmond Agitation Scale (score: +4 - -5; +4=aggressive behavior, 0=calm,-5=not reacting to verbal or physical approaches)
up to discharge from intensive care unit, an average of 30 days
Acute organ dysfunction - Confusion Assessment Method for the ICU (CAM-ICU)
기간: up to discharge from intensive care unit, an average of 30 days
CAM-ICU (score: 0-10; more than 2 errors= delirium)
up to discharge from intensive care unit, an average of 30 days
Persistent Organ Dysfunction - Incidence of mechanical ventilation
기간: Hospital discharge, day 30 after study inclusion, up to 3 months
need for ventilation
Hospital discharge, day 30 after study inclusion, up to 3 months
Persistent Organ Dysfunction - Incidence of hemodynamic parameters
기간: Hospital discharge, day 30 after study inclusion, up to 3 months
vasopressors
Hospital discharge, day 30 after study inclusion, up to 3 months
Persistent Organ Dysfunction - Incidence of renal replacement therapy
기간: Hospital discharge, day 30 after study inclusion, up to 3 months
renal replacement therapy
Hospital discharge, day 30 after study inclusion, up to 3 months
Complications - Rate of surgical reevaluation
기간: Hospital discharge, day 30 after study inclusion, up to 3 months
surgical reevaluation
Hospital discharge, day 30 after study inclusion, up to 3 months
Complications - Rate of hemorrhage
기간: Hospital discharge, day 30 after study inclusion, up to 3 months
hemorrhage
Hospital discharge, day 30 after study inclusion, up to 3 months
Complications - Rate of thromboembolic events
기간: Hospital discharge, day 30 after study inclusion, up to 3 months
thromboembolic events
Hospital discharge, day 30 after study inclusion, up to 3 months
Complications - Rate of cardiovascular events
기간: Hospital discharge, day 30 after study inclusion, up to 3 months
cardiovascular events
Hospital discharge, day 30 after study inclusion, up to 3 months
Complications - Rate of infection
기간: Hospital discharge, day 30 after study inclusion, up to 3 months
infection
Hospital discharge, day 30 after study inclusion, up to 3 months
Complications - Rate of sepsis
기간: Hospital discharge, day 30 after study inclusion, up to 3 months
sepsis
Hospital discharge, day 30 after study inclusion, up to 3 months

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2019년 1월 4일

기본 완료 (실제)

2020년 5월 4일

연구 완료 (실제)

2020년 5월 4일

연구 등록 날짜

최초 제출

2019년 11월 7일

QC 기준을 충족하는 최초 제출

2019년 11월 25일

처음 게시됨 (실제)

2019년 11월 29일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2022년 5월 26일

QC 기준을 충족하는 마지막 업데이트 제출

2022년 5월 25일

마지막으로 확인됨

2022년 5월 1일

추가 정보

이 연구와 관련된 용어

추가 관련 MeSH 약관

기타 연구 ID 번호

  • 19-001

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

심장 수술 환자에 대한 임상 시험

3
구독하다